Lista de obras - Evan B Cunningham - Dominio Público Uruguay

A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs – do gender differences vary by country-level indicators?

artículo científico publicado en 2019

Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia

article

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy

artículo científico publicado en 2019

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

artículo científico publicado en 2017

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis

artículo científico publicado en 2020

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study

article

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study

artículo científico publicado en 2017

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

artículo científico publicado en 2022

Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study

scientific article published on 12 November 2019

Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis

scholarly article by Behzad Hajarizadeh et al published November 2018 in The lancet. Gastroenterology & hepatology

Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, Canada

scientific article published on 06 June 2019

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study

artículo científico publicado en 2017

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial

artículo científico publicado en 2020

Frequency of injecting among people who inject drugs: A systematic review and meta-analysis

artículo científico publicado en 2019

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

artículo científico publicado en 2017

Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence

artículo científico publicado en 2020

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

artículo científico publicado en 2017

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

artículo científico publicado en 2018

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

scientific article published on 27 November 2019

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse

artículo científico publicado en 2017

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review.

artículo científico

Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study

artículo científico publicado en 2018

Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada

artículo científico publicado en 2015

Mixed HCV infection and reinfection in people who inject drugs--impact on therapy

artículo científico

Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.

artículo científico publicado en 2017

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

artículo científico publicado en 2017

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

artículo científico publicado en 2018

The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis

artículo científico publicado en 2019

Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection

scientific article published on 13 August 2019

Lista de obras de Evan B Cunningham

A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs – do gender differences vary by country-level indicators?

Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study

Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis

Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, Canada

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial

Frequency of injecting among people who inject drugs: A systematic review and meta-analysis

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review.

Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study

Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada

Mixed HCV infection and reinfection in people who inject drugs--impact on therapy

Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis

Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection